| Literature DB >> 20338878 |
Jeffrey T Olimpo1, Jeffrey J DeStefano.
Abstract
Human immunodeficiency virus reverse transcriptase (HIV-RT) binds more stably in binary complexes with RNA-DNA versus DNA-DNA. Current results indicate that only the -2 and -4 RNA nucleotides (-1 hybridized to the 3' recessed DNA base) are required for stable binding to RNA-DNA, and even a single RNA nucleotide conferred significantly greater stability than DNA-DNA. Replacing 2'- hydroxyls on pivotal RNA bases with 2'-O-methyls did not affect stability, indicating that interactions between hydroxyls and RT amino acids do not stabilize binding. RT's K(d) (k(off)/k(on)) for DNA-DNA and RNA-DNA were similar, although k(off) differed almost 40-fold, suggesting a faster k(on) for DNA-DNA. Avian myeloblastosis and Moloney murine leukemia virus RTs also bound more stably to RNA-DNA, but the difference was less pronounced than with HIV-RT. We propose that the H- versus B-form structures of RNA-DNA and DNA-DNA, respectively, allow the former to conform more easily to HIV-RT's binding cleft, leading to more stable binding. Biologically, the ability of RT to form a more stable complex on RNA-DNA may aid in degradation of RNA fragments that remain after DNA synthesis.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20338878 PMCID: PMC2910049 DOI: 10.1093/nar/gkq169
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 16.971
Dissociation rate constants (koff) and equilibrium dissociation constants (Kd) for RT-substrate complexes
| P33-D50 | 0.90 ± 0.12 | 1 | 2.7 ± 1.3 |
| P33-D15R5D30 | 0.024 ± 0.006 | 38 | 1.4 ± 0.6 |
| P33-D15R4D31 | 0.030 ± 0.006 | 30 | |
| P33-D15R3D32 | 0.13 ± 0.04 | 6.9 | |
| P33-D15R2D33 | 0.16 ± 0.04 | 5.6 | |
| P33-D15R1D34 | 0.41 ± 0.07 | 2.2 | 2.6 ± 1.3 |
| P33-D15R1(–1)D34 | 0.41 ± 0.07 | 2.2 | 2.6 ± 1.3 |
| P33-D16R1(–2)D33 | 0.11 ± 0.02 | 8.2 | 1.5 ± 0.3 |
| P-33-D17R1(–3)D32 | 0.25 ± 0.05 | 3.6 | |
| P33-D18R1(–4)D31 | 0.066 ± 0.012 | 14 | |
| P33-D16R1(–2)D1R1(–4)D31 | ≤0.024 | ≥38 | |
| P33-D18R1(–4U>G)D31 | 0.19 ± 0.05 | 4.7 | |
| P33-D18R1(–4U>C)D31 | 0.11 ± 0.02 | 8.2 | |
| P33-D18r1(–4U>A)D31 | 0.18 ± 0.04 | 5 | |
| P33-D16R1(–2U>A)D33 | 0.090 ± 0.006 | 10 | |
| P33-D16R1(–2U>C)D33 | 0.11 ± 0.01 | 8.2 | |
| P35-D18R1(–4>−6)D31 | 0.39 ± 0.06 | 2.3 | |
| P34-D18R1(–4>−5)D31 | 0.11 ± 0.01 | 8.2 | |
| P32-D18R1(−4>−3)D31 | 0.66 ± 0.06 | 1.4 | |
| P31-D18R1(−4>−2)D31 | 0.34 ± 0.09 | 2.6 | |
| P33-D18methylR1(–4)D31 | 0.042 ± 0.006 | 21 | |
| P33-D15methylR5D30 | 0.030 ± 0.006 | 30 | 1.6 ± 1.0 |
| S2P33-D50 | 9.3 ± 3.2 | 1 | |
| S2P33-D15R5D30 | 0.10 ± 0.03 | 93 | |
| S2P33-D18R1(–4)D31 | 0.54 ± 0.02 | 17 | |
| S2P33-D18R1(–4A>U)D31 | 0.25 ± 0.01 | 37 | |
| S2P33-D16R1(–2)D1R1(–4)D31 | 0.12 ± 0.01 | 78 | |
| AMV, P33-D50 | 0.10 ± 0.02 | 1 | 2.8 ± 1.0 |
| AMV, P33-D15R5D30 | ≤0.024 | ≥4.2 | 2.1 ± 0.8 |
| MuLV-RT, P33-D50 | 0.16 ± 0.02 | 1 | |
| MuLV-RT, P33-D15R5D30 | 0.078 ± 0.024 | 2.1 | |
| HIV-RT, P33-D50 | 1.3 ± 0.1 | 1 | |
| HIV-RT, P33-R50 | 0.048 ± 0.012 | 27 | |
| AMV, P33-D50 | 0.96 ± 0.06 | 1 | |
| AMV, P33-R50 | 0.43 ± 0.18 | 2.2 | |
| MuLV-RT, P33-D50 | 0.33 ± 0.02 | 1 | |
| MuLV-RT, P33-R50 | 0.14 ± 0.05 | 2.4 | |
aFor an illustration of the duplex sequences and configurations see Figure 1.
bkoff or Kd for HIV-RT on the specific duplexes; see ‘Materials and Methods’ section for an explanation of how this was determined; results are an average of two to four independent experiments ± standard deviation.
cAll numbers are relative to the specific DNA–DNA duplex of homologous sequence which was set equal to 1; larger numbers indicate slower dissociation of RT and tighter binding.
*These two substrates are identical
**koff was too low to be reliably determined under the conditions used; numbers provided indicate that it was at least as low as the lowest measured off-rate in the assays.
***Assays were performed without Mg2+ in dissociation phase and with 20 rather than 80 mM KCl in order to help stabilize binding, which is weaker in the absence of Mg2+.
Figure 1.Sequence and configuration of nucleic acid substrates. (A) Representative sequences of the short DNA (top stand, denoted ‘P33’ for ‘Primer’ 33 nt) and long (DNA, or RNA–DNA chimera) strands are shown. Five different short DNA strands that shared a common 5′-end were used. There lengths were 31, 32, 33, 34 and 35. Only the 33-nt strand that was used for most substrates is shown. In order to illustrate the nomenclature used in the text, the shorter DNA is placed over the complementary bases of three of the several different template strands that were used. The templates were all 50 nt and consisted of either homogeneous DNA or RNA, or chimeras with both DNA and RNA. RNA nucleotides are underlined on the templates. Duplex substrates were named based on the short DNA and template used with the following nomenclature as an example: P33-D18R1(–4)D31. This substrate had the 33 nt DNA hybridized to a template strand where the first 18 5′ nt were DNA, followed by a single RNA nucleotide, then 31 DNA nucleotides. The −4 in parentheses indicates the position of the single RNA nucleotide relative to the 3′ terminus of P33 with the template nucleotide hybridized to the 3′ terminal base being designated as −1. This basic nomenclature was used for all substrates described in the text. (B) A second duplex with a different sequence that was used in experiments is shown. These substrates are designated ‘S2’ (sequence 2) in the text. Nomenclature is as stated above.
Figure 2.Panels for dissociation rate constants (koff) (A), and dissociation equilibrium constants (Kd) (B). (A) Representative assays are shown to illustrate how dissociation rate constants were determined. This set of assays corresponds to the section in Table 1 labeled‘Binding of RT to duplexes with one or two RNA nucleotides in the template’. Primer labeled with 32P at the 5′-end was used in the assays. The level of primer extension over time was quantified using a phosphoimager as described in ‘Materials and Methods’ section and these values were plotted to determine koff.Time points used for the P33-D50 assay were 0, 15 s, 30 s, 1 m, 1.5 m, 2 m, 2.5 m, 3 m and 4 m, while for all other assays time points were 0, 30 s, 1 m, 2 m, 4 m, 8 m and 16 m. Lane A in each panel shows a reaction in the absence of enzyme. Lane B shows a control reaction to test the effectiveness of the heparin trap (see ‘Materials and Methods’ section). In this reaction, the enzyme was mixed with the trap and the mixture was added to the substrate in the presence of dNTPs and divalent cation and incubated for 10 min before termination. Lane C shows a full extension control in which enzyme was incubated with the substrate as in the trap control reaction except trap was omitted to allow all the bound primer to be extended. (B) Representative assays are shown to illustrate how dissociation equilibrium constants were determined. Panels are labeled at the top with the primer-template that was used in the assay. The concentration of RT (nM) is noted above each lane. Other labels are as above for 2A. Refer to Table 1 for Kd results.